Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.
Press releases published on June 15, 2025
Clean Group Expands Eco-Friendly Commercial Cleaning Services Across Australia and NZ
EIN Presswire
·
June 15, 2025
Clean Group, a trusted ISO-certified company, now offers 24/7 eco-friendly cleaning services across Sydney, Melbourne, Brisbane, and Auckland. SYDNEY, NSW, AUSTRALIA, June 16, 2025 /EINPresswire.com/ -- Clean Group, a leading ISO-certified commercial …
CPR Classes Near Me Opens New Location in Miami Lakes to Serve Hialeah and Surrounding Areas
EIN Presswire
·
June 15, 2025
MIAMI LAKES, FL, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- CPR Classes Near Me, a nationally trusted provider of American Heart Association (AHA) CPR and First Aid certification, has opened its newest location at 6625 Miami Lakes Dr #101, Miami …
ClearView Imaging Center offering free heart scans
EIN Presswire
·
June 15, 2025
Free Heart Artery Calcium Score For All Patients THE VILLAGES, FL, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- ClearView Imaging Center is proud to announce the grand opening of its state-of-the-art diagnostic imaging facility at 3325 Wedgewood …
Wellness Brand Amazing Sesame Establishes Presence in Laos
EIN Presswire
·
June 15, 2025
Amazing Sesame expands its inside-out beauty and wellness mission fostering confidence through health and radiance. LAOS, LAOS, June 15, 2025 /EINPresswire.com/ -- Amazing Sesame, a wellness-focused brand rooted in the traditional Taiwanese art of black …
Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21
EIN Presswire
·
June 15, 2025
Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- In a time when public health and …
Biomonitoring Programs Reveal Widespread PFAS Exposure in U.S. Population
EIN Presswire
·
June 15, 2025
PFAS blood testing helps uncover hidden exposure—Legal Claim Assistant explains how biomonitoring supports health and legal action. MIAMI, FLORIDA, FL, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- As part of nationwide environmental health …
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
GlobeNewswire
·
June 15, 2025
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core …
Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute 1ere étude respiratoire de ph4 en comparaison directe …
GlobeNewswire
·
June 15, 2025
EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
GlobeNewswire
·
June 15, 2025
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …
Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
GlobeNewswire
·
June 15, 2025
New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …
Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices
EIN Presswire
·
June 15, 2025
New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- Tom Jackobs, international sales strategist, is now offering …
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress
GlobeNewswire
·
June 15, 2025
With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF
GlobeNewswire
·
June 15, 2025
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF). Such investors are advised to contact Danielle Peyton at …
Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
GlobeNewswire
·
June 15, 2025
– Pharmacology modeling data presented at the European Academy of Allergy …
D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth
GlobeNewswire
·
June 15, 2025
Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …